JJ
James W. Newman Jr.
Director

James W. Newman Jr. insider trades: Adial Pharmaceuticals (ADIL) stock purchases

Director, Adial Pharmaceuticals Last trade Dec 30, 2021 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2020
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where James reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 30, 2021ADIL↑ Buy$27K
Dec 30, 2021ADIL↑ Buy$27K
Dec 30, 2021ADIL↑ Buy$14K
Nov 26, 2021ADIL↑ Buy$29K
Mar 27, 2020ADIL↑ Buy$13K
Mar 27, 2020ADIL↑ Buy$7K
Mar 27, 2020ADIL↑ Buy$6K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ADIL insiders

Open-market trades in the last 12 months

About James W. Newman Jr.'s insider trades

James W. Newman Jr. is a director at Adial Pharmaceuticals (ADIL). Since Mar 27, 2020, James has reported 7 open-market purchases worth $123K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (7 filings), other transactions (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADIL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.